Search clinical trials for: 18F-Raltegravir

Total 2780 results

National Institute on Alcohol Abuse and Alcoholism...

Completed

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

Normal Physiology

United States
University Health Network, Toronto

Active, not recruiting

PSMA PET Registry (18F-DCFPyL) (PM-PPR)

Carcinoma of Prostate

Canada
Ashok Muthukrishnan
Progenics Pharmaceuticals, Inc.

Terminated

18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer

Prostate Cancer

United States
National Institute of Mental Health (NIMH)

Completed

[18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects

Healthy

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer

Breast Cancer

United States
University Hospital, Ghent

Completed

PSMA-PET/CT for Prostate Cancer (NGP1)

Prostate Cancer

Belgium
Harbin Medical University

Completed

EGFR Molecular Classification In Vivo

Molecular Imaging

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
Prostate Cancer Foundation; Radiological Society of North America

Completed

Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer

Prostate Cancer

United States
University Hospital, Bordeaux

Terminated

Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke (PLAQINSTEP)

Stroke

France
Oriental Neurosurgery Evidence-Based-Study Team

Unknown

18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia

Neurodegenerative Dementia

China
Navidea Biopharmaceuticals

Unknown

Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI) (NAV4-04)

Mild Cognitive Impairment

United States
Navidea Biopharmaceuticals

Unknown

Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease

Alzheimer Disease

United States
GlaxoSmithKline

Terminated

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Institute for Neurodegenerative Disorders

Completed

Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (PBR111)

Alzheimer Disease

United States
Centre Hospitalier St Anne
Roche Pharma AG

Recruiting

Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease (GliSyn)

Alzheimer Disease

France
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Carcinoma, Bronchogenic | Lymphoma, Malignant | Breast Carcinoma | Cancer of Head and Neck | Soft Tissue Neoplasms | Tumors

China
Fundación Pública Andaluza para la Investigación...
Merck Sharp & Dohme LLC

Unknown

Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD Study (NEARQD)

HIV Infections

Spain
Queen Mary University of London
Merck Sharp & Dohme LLC

Completed

Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis (INSPIRE)

Relapsing Remitting Multiple Sclerosis

United Kingdom
The Miriam Hospital
Merck Sharp & Dohme LLC; Tufts Medical Center

Completed

Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy

HIV Infections | HIV | Hypertriglyceridemia | Hyperlipidemia

United States
University of California, Los Angeles
University Health Network, Toronto; Merck Sharp & Dohme LLC; Tufts University; Vanderbilt... and other collaborators

Completed

Raltegravir Therapy for Women With HIV and Fat Accumulation

HIV Infections | Lipodystrophy

United States, Canada
Stanford University

Completed

RAL-eve Study: Raltegravir Substitution Study

HIV Infections

United States
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir (OPAL)

HIV Infections | HCV Infections

Netherlands
Merck Sharp & Dohme LLC

Completed

A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)

Human Immunodeficiency Virus
Pfizer

Completed

Drug Interaction Study Between Raltegravir And UK-453,061

Healthy Volunteers

United States
Guy's and St Thomas' NHS Foundation Trust
King's College London

Not yet recruiting

Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET

Cancer | Diagnosis | Resistant Cancer | Response, Acute Phase
Assistance Publique - Hôpitaux de Paris

Recruiting

Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation (SMARTinMS)

Multiple Sclerosis | Inflammatory Disease

France
University College, London
Imperial College London; Cancer Research UK; National Cancer Imaging Translational...

Recruiting

[18F]FPIA PET/CT Imaging in Patients With Solid Tumours ([18F]FPIA)

Cancer | Tumor, Solid

United Kingdom
The First Affiliated Hospital of Guangzhou Medical...

Unknown

The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones

Renal Calculi

China
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA) (GRAPPA)

HIV Infections

Netherlands
Peking Union Medical College Hospital

Unknown

18F-FDG PET/CT for IgG4-Related Disease

Autoimmune Disease

China
National Cancer Institute (NCI)

Completed

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Kidney Cancer | Hippel-Lindau Disease

United States
Fondazione Penta UK
UCL Great Ormond Street Institute of Child Health

Recruiting

Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)

HIV Infections

Spain, Switzerland, United Kingdom, Belgium, Italy, Romania, Russian Federation
The HIV Netherlands Australia Thailand Research...
Chulalongkorn University; National Healthcare Group Pte Ltd, Singapore

Completed

Pharmacokinetics of Low Dose Raltegravir

HIV Infections

Thailand
University of Miami
Merck Sharp & Dohme LLC

Terminated

Addition of Raltegravir to Established Antiretroviral Suppressive Therapy

HIV

United States
University of Arkansas

Withdrawn

Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy

Squamous Cell Carcinoma of the Head and Neck

United States
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

HIV Infections

Spain
Germans Trias i Pujol Hospital

Completed

Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product

HIV Infections

Spain
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

HIV Infections

United States, South Africa, Brazil, Tanzania, Thailand
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC

Completed

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients (LIVERAL)

Liver Failure | HIV Infection | Evidence of Liver Transplantation

France
Angela Kashuba, PharmD
Merck Sharp & Dohme LLC

Completed

Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers

Healthy Volunteer

United States
CellSight Technologies, Inc.

Not yet recruiting

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

Advanced Non Small Cell Lung Cancer
First Affiliated Hospital of Zhejiang University

Not yet recruiting

18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.

18F-HER2 PET

China
IRCCS San Raffaele

Not yet recruiting

18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer

Prostate Cancer
University of Alabama at Birmingham

Recruiting

18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot Study

Prostate Cancer

United States
University of Alberta

Recruiting

18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028

Prostate Cancer

Canada
Universitaire Ziekenhuizen KU Leuven

Recruiting

In Vivo PET of Synaptic Density in Cognitive Disorders

Alzheimer Disease | Frontotemporal Degeneration | Psychiatric Disorder | Dementia With Lewy Bodies

Belgium
University of Edinburgh

Completed

PET/MR Imaging In Patients With Cardiac Amyloidosis

Cardiac Amyloidosis

United Kingdom
Center Eugene Marquis

Withdrawn

Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma. (INFLAGLI)

Glioma
University of California, Davis

Enrolling by invitation

PET/CT Imaging in COVID-19 Patients

COVID-19 | SARS-CoV-2 Infection

United States
GE Healthcare

Completed

A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes

Ischemic Heart Disease | Coronary Artery Disease (CAD)

United States

Search clinical trials for: 18F-Raltegravir

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations